Über uns
Über uns
Führungsteam
Partnerschaften
Unsere Standorte
Technologie
Technologie
Produktion
Publikationen
Pipeline
Newsroom
News
Events
Downloads
Investor Relations
Überblick
Aktieninformation
Analysten-Coverage
Außerordentliche Hauptversammlung 2023
Finanzberichte
Corporate Governance
E-Mail Alert
Karriere
Werden Sie Teil der RNA people
Ausbildung
Aktuelle Stellenangebote
DE
Natural mRNA
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
by Sovereign
Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals
by Sovereign
A development, that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
by Sovereign
